Literature DB >> 17229611

HIV - associated and non - HIV associated types of Kaposi's sarcoma in an African population in Tanzania. Status of immune suppression and HHV-8 seroprevalence.

G Wamburu1, E J Masenga, E Z Moshi, P Schmid-Grendelmeier, W Kempf, C E Orfanos.   

Abstract

In this study 77 patients with histologically confirmed Kaposi's sarcoma (KS) were seen at the Regional Dermatology Training Centre (RDTC) in Moshi, Tanzania. Sixty six patients (85.7%) were HIV-seropositive KS-patients (40 males, 26 females; male: female ratio 1.5:1), whereas another 11 (14.3%) KS-patients, all males, were found HIV-seronegative, thus corresponding to the endemic African KS-type. In both groups the CD4+ cell counts were generally low, the CD8+ population increased and the CD4+/CD8+ ratio inverted. Immune suppression was, however, more prominent in the HIV-seropositive group.HHV-8 seroprevalence was high in patients with HIV-associated KS (94.6%), nevertheless, 3 (5.4%) patients in this group remained HHV-8 seronegative. All nine patients with the HIV-seronegative African type of KS were found positive for HHV-8. Of the entire group seen, males were more likely to be HHV-8 seropositive than females (OR = 3.348 95% CI, 0.96-11.65; p < 0.05). The relative risk to develop KS in individuals seropositive to both HIV and HHV-8 was high (OR = 10.6, 95% CI; 2.981-37.688; p < 0.001).Overall, HIV-associated KS differed from the non-HIV-associated by its widespread clinical dissemination on the trunk, the frequent involvement of the oral mucosa and the craniofacial region, and its more rapidly progressive course. No histological differences between the two KS-groups were seen, although spindle cell infiltrates were more often found in the HIV-associated KS-group.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17229611

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  7 in total

1.  Binding of the Kaposi's sarcoma-associated herpesvirus to the ephrin binding surface of the EphA2 receptor and its inhibition by a small molecule.

Authors:  Alexander S Hahn; Ronald C Desrosiers
Journal:  J Virol       Date:  2014-06-04       Impact factor: 5.103

2.  Human herpesvirus-8 (HHV-8) sero-detection and HIV association in Kaposi's sarcoma (KS), non-KS tumors and non-neoplastic conditions.

Authors:  Amos R Mwakigonja; Pawan Pyakurel; Parviz Kokhaei; Fatemeh Pak; Leonard K Lema; Ephata E Kaaya; Peter Biberfeld
Journal:  Infect Agent Cancer       Date:  2008-06-30       Impact factor: 2.965

3.  Anogenital Lesions: Kaposi's Sarcoma and Its Mimicks.

Authors:  Louis-Jacques van Bogaert
Journal:  ISRN AIDS       Date:  2012-10-31

4.  Clinicopathological Proficiency in the Diagnosis of Kaposi's Sarcoma.

Authors:  Louis-Jacques van Bogaert
Journal:  ISRN AIDS       Date:  2012-05-30

Review 5.  Herpesvirus Respiratory Infections in Immunocompromised Patients: Epidemiology, Management, and Outcomes.

Authors:  Gail E Reid; Joseph P Lynch; Samuel Weigt; David Sayah; John A Belperio; Shellee A Grim; Nina M Clark
Journal:  Semin Respir Crit Care Med       Date:  2016-08-03       Impact factor: 3.119

6.  Histopathological patterns and topographical distribution of Kaposi Sarcoma at Muhimbili National Hospital, Tanzania.

Authors:  Reginald Gervas; Edward Mgaya
Journal:  Afr Health Sci       Date:  2021-12       Impact factor: 0.927

7.  Atypical presentation of classic Kaposi sarcoma in circumcised penis presenting as an ulcerative nodule with human herpesvirus 8 (HHV8) positivity and successfully treated with only local excision.

Authors:  Abdulaziz Alamri; B K Adiga
Journal:  Infect Agent Cancer       Date:  2019-12-02       Impact factor: 2.965

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.